Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.The initial reporter phone: (b)(6).The initial reporter email address was not available / reported.[conclusion]: the healthcare professional reported that during an endovascular embolization procedure, the complaint device, a 4 mm x 39 mm enterprise®2 stent (encr403912 / 6920565) was released to the end of the positioning markers, but the proximal stent markers were found to be completely unopened.The physician retracted the stent and the microcatheter, a 150cm x 5cm, 2 markers prowler select plus microcatheter (606s255x / 30734772) and found that the microcatheter had become kinked / bent in during the process.A new stent and a new microcatheter were used to complete the procedure.There was no report of any negative patient impact.On 01-dec-2022, additional information was received.The information indicated that the target aneurysm was a regular unruptured aneurysm with the following dimensions: 5.3mm x 4.7mm x 4.1mm.There were no vessel nor aneurysm factors that may have contributed to the incomplete expansion.There was no evidence of obstructed blood flow due to reported event.The temperature indicator label on the inner pouch was checked and determined to be within acceptable criteria.There was no resistance during the advancement of the stent.The information indicated that the replacement stent was another 4 mm x 39 mm enterprise®2 stent (encr403912) and the replacement microcatheter was another prowler select plus microcatheter (606s255x).There was no clinically significant delay in the procedure due to the reported issue.On 05-dec-2022, additional information was received confirming that the distal markers were the markers that remained unopened.Based on complaint information, the device is not available to be returned for analysis.(b)(4) performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot 6920565 the history record indicates this product was final inspection tested at (b)(4) and was determined to be acceptable.Product analysis cannot be conducted as the product was not returned for analysis.No determination of causes and possible contributing factors could be made.As such, the investigation will be closed.With the information available and without the complaint product available to be returned for analysis, the reported issue in the complaint cannot be confirmed.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.Assignment of root cause for the event remains speculative and inconclusive, based on the limited information provided and without the return of the complaint sample; however, it is possible that clinical and procedural factors, including device manipulation / interaction may have contributed to the reported failure.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
The healthcare professional reported that during an endovascular embolization procedure, the complaint device, a 4 mm x 39 mm enterprise®2 stent (encr403912 / 6920565) was released to the end of the positioning markers, but the distal stent markers were found to be completely unopened.The physician retracted the stent and the microcatheter, a 150cm x 5cm, 2 markers prowler select plus microcatheter (606s255x / 30734772) and found that the microcatheter had become kinked / bent in during the process.A new stent and a new microcatheter were used to complete the procedure.There was no report of any negative patient impact.On 01-dec-2022, additional information was received.The information indicated that the target aneurysm was a regular unruptured aneurysm with the following dimensions: 5.3mm x 4.7mm x 4.1mm.There were no vessel nor aneurysm factors that may have contributed to the incomplete expansion.There was no evidence of obstructed blood flow due to reported event.The temperature indicator label on the inner pouch was checked and determined to be within acceptable criteria.There was no resistance during the advancement of the stent.The information indicated that the replacement stent was another 4 mm x 39 mm enterprise®2 stent (encr403912) and the replacement microcatheter was another prowler select plus microcatheter (606s255x).There was no clinically significant delay in the procedure due to the reported issue.On 05-dec-2022, additional information was received confirming that the distal markers were the markers that remained unopened.
|